For much of her life, 16-year-old Abigail Weightman lived in a haze.
The Pickering resident suffers from Dravet Syndrome — an incurable, rare form of epilepsy that causes seizures, significant developmental delays and learning disabilities.
Her family tried 14 different medications over the years to manage her seizures, said Abigail’s mother, Laura.
Nothing really worked, until she became part of a new study on the effects of cannabis oil on children with drug-resistant epilepsy. Before the study, Abigail was having eight to 10 seizures a month. Since trying this specific cannabis oil treatment, she has only had three seizures in all of 2018, and none in the last two months.
“It’s amazing,” Laura Weightman said. “It’s life changing.”
The study, which was conducted by Toronto’s SickKids Hospital and sponsored by medical cannabis company Tilray, is the first Canadian pediatric study of mixed THC and CBD cannabis oil, said Dr. Blathnaid McCoy, staff neurologist at SickKids.
The peer-reviewed study was published Wednesday in the Annals of Clinical and Translational Neurology.